Loading…
Merit Medical Systems entered into an Asset Purchase Agreement to acquire a tunneled home drainage catheter product line from C.R. Bard and a soft tissue core needle biopsy product line from BD for $100 million, contingent on the BD-Bard merger closing.
BD (Becton, Dickinson and Company) announced a definitive agreement to acquire C. R. Bard, Inc. for $317.00 per share in cash and stock, total consideration $24 billion. The transaction is expected to be immediately accretive and generate cost synergies.